相关实验视频
Updated: Sep 16, 2025

11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
10.5K
在瘤相关炎症中准O-GlcNAcylation:从分子机制到癌症治疗
Rui Shi1, Ling Gao2, Shao-Ming Li2
1Department of Oral and Maxillofacial Reconstruction, the Affiliated Hospital of Qingdao University, Qingdao 266555, China; School of Stomatology of Qingdao University, Qingdao, China; Department of Oral and Maxillofacial Surgery, the Affiliated Hospital of Qingdao University, Qingdao 266555, China.
Critical reviews in oncology/hematology
|July 4, 2025
概括
一种蛋白质修饰的O-GlcNAcylation会影响癌症的发展. 了解其与炎症的联系为向癌症治疗和改进治疗策略提供了新的途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- O-GlcNAcylation是一种动态的翻译后修饰,在细胞信号传输中至关重要.
- 对O-GlcNAcylation的失调与癌症进展有关.
- 炎症是瘤发展的关键因素,也是癌症干预的目标.
研究的目的:
- 探索将O-GlcNAcylation和癌症中的炎症反应联系在一起的复杂机制.
- 总结O-GlcNAcylation调节的炎症在瘤治疗中的作用.
- 为新的向癌症治疗提供理论基础.
主要方法:
- 文献综述和现有关于O-GlcNAcylation和癌症相关炎症的研究的综合.
- 在瘤中分析O-GlcNAcylation通路和炎症网络之间的相互作用.
- 评估针对这些相互连接的途径的治疗策略.
主要成果:
- 在O-GlcNAcylation周期中的不平衡对于癌症的开始和进展至关重要.
- 针对与炎症相关的途径,可能由O-GlcNAcylation调节,显示出治疗前景.
- 了解瘤特异性炎症的时空动态对于精确瘤学至关重要.
结论:
- O-GlcNAcylation和炎症之间的相互作用是开发创新的癌症治疗方法的重要领域.
- 对这些机制的进一步研究可以为更有效,更有针对性的癌症疗法铺平道路.
- 本综述为未来利用瘤学中O-GlcNAcylation-inflammation轴的临床策略提供了基础.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Proteoglycans
4.0K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

